177lu-psma-617
novartis
['crpc']
vision: among men with psma-positive mcrpc on pet/ct treated with 177lu-psma-617, a higher suvmean was associated with improved long-term clinical outcomes
#asco22 
Medical oncologist. Lung and genitourinary cancer.
#lcsm #pcsm #kcsm